Despite concerns raised by clinicians and ethicists, direct-to-consumer testing for Alzheimer’s disease biomarkers is here, ...

Quest Diagnostics has signed up to offer a blood test that can help diagnose Alzheimer’s disease, following its FDA clearance earlier this year. | The Lumipulse G blood test measures the ratio between ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Quest Diagnostics to offer US FDA-approved Fujirebio blood test for Alzheimer's disease: Secaucus, New Jersey Friday, July 11, 2025, 14:00 Hrs [IST] Quest Diagnostics, a leader in ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, including advanced diagnostics for brain health, today announced it plans to offer laboratory testing based on the ...

Time Course of Alzheimer's Disease Damage from the disease begins to accrue years or decades before any symptoms begin. A given individual presenting at age 70 might be expected to spend a decade ...

Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer’s Disease Mahdieh Anoush ...

Alzheimer's Disease : Alzheimer’s Disease Center of Excellence includes the latest research, journal articles, cases, quizzes, and peer discussion about Alzheimer’s disease.

Sensory Stimulation Systems, and GENUS, refer to a noninvasive procedure, i.e., a "digital therapeutic," being developed by Cognito Therapeutics. The company developed a wearable GammaSense ...

New research reveals that Alzheimer's disease may impair nerve function not by reducing myelin, but by altering the proteins at the critical interface between axons and their myelin sheath.

As Taiwan begins administering two newly approved drugs for early-stage Alzheimer’s disease, more accurate diagnostic tools are needed to identify suitable patients and guide treatment decisions, ...

After decades of research, the U.S. Food and Drug Administration (FDA) has approved a test that can detect the buildup of amyloid plaques in the brain—a key marker of Alzheimer’s disease, according to ...